Improvement in patient-reported “taste” and association with smell in dupilumab-treated patients with severe chronic rhinosinusitis with nasal polyps from the SINUS-24 and SINUS-52 trials

Anju T. Peters; Zachary M. Soler; Robert C. Kern; Enrico Heffler; Jorge F. Maspero; Louis Crampette; Shigeharu Fujieda; Andrew P. Lane; Haixin Zhang; Scott Nash; Asif H. Khan; Shahid Siddiqui; Juby A. Jacob-Nara; Paul Rowe; Yamo Deniz

doi:10.1111/cea.14194

Improvement in patient-reported “taste” and association with smell in dupilumab-treated patients with severe chronic rhinosinusitis with nasal polyps from the SINUS-24 and SINUS-52 trials

Anju T. Peters^*, Zachary M. Soler, Robert C. Kern, Enrico Heffler, Jorge F. Maspero, Louis Crampette, Shigeharu Fujieda, Andrew P. Lane, Haixin Zhang, Scott Nash, Asif H. Khan, Shahid Siddiqui, Juby A. Jacob-Nara, Paul Rowe, Yamo Deniz

^*Corresponding author for this work

Research output: Contribution to journal › Letter › peer-review

3 Scopus citations

Original language	English (US)
Pages (from-to)	1105-1109
Number of pages	5
Journal	Clinical and Experimental Allergy
Volume	52
Issue number	9
DOIs	https://doi.org/10.1111/cea.14194
State	Published - Sep 2022

Funding

Research sponsored by Sanofi and Regeneron Pharmaceuticals, Inc. ClinicalTrials.gov Identifiers: NCT02898454 (SINUS‐52) and NCT02912468 (SINUS‐24). Medical writing/editorial assistance provided by Stephen Whiting, PhD, of Adelphi Group, funded by Sanofi Genzyme and Regeneron Pharmaceuticals, Inc. Research sponsored by Sanofi and Regeneron Pharmaceuticals, Inc. ClinicalTrials.gov Identifiers: NCT02898454 (SINUS-52) and NCT02912468 (SINUS-24). Medical writing/editorial assistance provided by Stephen Whiting, PhD, of Adelphi Group, funded by Sanofi Genzyme and Regeneron Pharmaceuticals, Inc.

ASJC Scopus subject areas

Immunology and Allergy
Immunology

Access to Document

10.1111/cea.14194

Cite this

Peters, A. T., Soler, Z. M., Kern, R. C., Heffler, E., Maspero, J. F., Crampette, L., Fujieda, S., Lane, A. P., Zhang, H., Nash, S., Khan, A. H., Siddiqui, S., Jacob-Nara, J. A., Rowe, P., & Deniz, Y. (2022). Improvement in patient-reported “taste” and association with smell in dupilumab-treated patients with severe chronic rhinosinusitis with nasal polyps from the SINUS-24 and SINUS-52 trials. Clinical and Experimental Allergy, 52(9), 1105-1109. https://doi.org/10.1111/cea.14194

@article{2b1240c910294b808e00a7a21ec68bc5,

title = "Improvement in patient-reported “taste” and association with smell in dupilumab-treated patients with severe chronic rhinosinusitis with nasal polyps from the SINUS-24 and SINUS-52 trials",

author = "Peters, {Anju T.} and Soler, {Zachary M.} and Kern, {Robert C.} and Enrico Heffler and Maspero, {Jorge F.} and Louis Crampette and Shigeharu Fujieda and Lane, {Andrew P.} and Haixin Zhang and Scott Nash and Khan, {Asif H.} and Shahid Siddiqui and Jacob-Nara, {Juby A.} and Paul Rowe and Yamo Deniz",

note = "Funding Information: Research sponsored by Sanofi and Regeneron Pharmaceuticals, Inc. ClinicalTrials.gov Identifiers: NCT02898454 (SINUS‐52) and NCT02912468 (SINUS‐24). Medical writing/editorial assistance provided by Stephen Whiting, PhD, of Adelphi Group, funded by Sanofi Genzyme and Regeneron Pharmaceuticals, Inc. Funding Information: Research sponsored by Sanofi and Regeneron Pharmaceuticals, Inc. ClinicalTrials.gov Identifiers: NCT02898454 (SINUS-52) and NCT02912468 (SINUS-24). Medical writing/editorial assistance provided by Stephen Whiting, PhD, of Adelphi Group, funded by Sanofi Genzyme and Regeneron Pharmaceuticals, Inc.",

year = "2022",

month = sep,

doi = "10.1111/cea.14194",

language = "English (US)",

volume = "52",

pages = "1105--1109",

journal = "Clinical and Experimental Allergy",

issn = "0954-7894",

publisher = "Wiley-Blackwell",

number = "9",

}

Peters, AT, Soler, ZM, Kern, RC, Heffler, E, Maspero, JF, Crampette, L, Fujieda, S, Lane, AP, Zhang, H, Nash, S, Khan, AH, Siddiqui, S, Jacob-Nara, JA, Rowe, P & Deniz, Y 2022, 'Improvement in patient-reported “taste” and association with smell in dupilumab-treated patients with severe chronic rhinosinusitis with nasal polyps from the SINUS-24 and SINUS-52 trials', Clinical and Experimental Allergy, vol. 52, no. 9, pp. 1105-1109. https://doi.org/10.1111/cea.14194

Improvement in patient-reported “taste” and association with smell in dupilumab-treated patients with severe chronic rhinosinusitis with nasal polyps from the SINUS-24 and SINUS-52 trials. / Peters, Anju T.; Soler, Zachary M.; Kern, Robert C. et al.
In: Clinical and Experimental Allergy, Vol. 52, No. 9, 09.2022, p. 1105-1109.

Research output: Contribution to journal › Letter › peer-review

TY - JOUR

T1 - Improvement in patient-reported “taste” and association with smell in dupilumab-treated patients with severe chronic rhinosinusitis with nasal polyps from the SINUS-24 and SINUS-52 trials

AU - Peters, Anju T.

AU - Soler, Zachary M.

AU - Kern, Robert C.

AU - Heffler, Enrico

AU - Maspero, Jorge F.

AU - Crampette, Louis

AU - Fujieda, Shigeharu

AU - Lane, Andrew P.

AU - Zhang, Haixin

AU - Nash, Scott

AU - Khan, Asif H.

AU - Siddiqui, Shahid

AU - Jacob-Nara, Juby A.

AU - Rowe, Paul

AU - Deniz, Yamo

N1 - Funding Information: Research sponsored by Sanofi and Regeneron Pharmaceuticals, Inc. ClinicalTrials.gov Identifiers: NCT02898454 (SINUS‐52) and NCT02912468 (SINUS‐24). Medical writing/editorial assistance provided by Stephen Whiting, PhD, of Adelphi Group, funded by Sanofi Genzyme and Regeneron Pharmaceuticals, Inc. Funding Information: Research sponsored by Sanofi and Regeneron Pharmaceuticals, Inc. ClinicalTrials.gov Identifiers: NCT02898454 (SINUS-52) and NCT02912468 (SINUS-24). Medical writing/editorial assistance provided by Stephen Whiting, PhD, of Adelphi Group, funded by Sanofi Genzyme and Regeneron Pharmaceuticals, Inc.

PY - 2022/9

Y1 - 2022/9

UR - http://www.scopus.com/inward/record.url?scp=85133936427&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85133936427&partnerID=8YFLogxK

U2 - 10.1111/cea.14194

DO - 10.1111/cea.14194

M3 - Letter

C2 - 35775319

AN - SCOPUS:85133936427

SN - 0954-7894

VL - 52

SP - 1105

EP - 1109

JO - Clinical and Experimental Allergy

JF - Clinical and Experimental Allergy

IS - 9

ER -

Improvement in patient-reported “taste” and association with smell in dupilumab-treated patients with severe chronic rhinosinusitis with nasal polyps from the SINUS-24 and SINUS-52 trials

Funding

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this